Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Take with food
The predominant effective dose used in mouse studies is 25 nmol/kg
Other important safety information Do not use GLP-1 if you have a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis
Continue for 16 to 24 weeks minimum before assessing results
If a medication is to be administered via the intrathecal/epidural route, only preservative-free diluents (such as sterile saline or sterile water) are appropriate
Boehringer Ingelheims Survodutide Survodutide (BI 456906), co-invented by Boehringer Ingelheim and Zealand Pharma, is an investigational glucagon/GLP-1 receptor dual agonist
US$ 22.89
US$ 20.02
US$ 22.44
US$ 24.60
US$ 21.88
